related content
Global vaccine scarcity unnecessary if pharma shares knowledge
In a joint letter, SOMO together with 53 civil society organisations are calling upon the Dutch government to ensure that pharmaceutical companies share their knowledge of vaccine development with other companies in an existing pool…
Response of SOMO and Wemos to Government reaction on report ‘Overpriced’
On 27 August 2020, the Dutch Ministry of Economic Affairs responded in a letter to the Parliament to the SOMO report ‘Overpriced: drugs developed with Dutch Public Funding‘. On our Dutch website you find a…
New research reveals large-scale tax avoidance by coronavirus test manufacturer Qiagen
New research by the Centre for Research on Multinational Corporations (SOMO) shows that the German coronavirus test producer Qiagen has been able to dodge millions of euros in tax since 2010 thanks to tax avoidance…
Profiting from a pandemic
How COVID-19 test kit producer Qiagen receives public money but avoids taxes
Dutch parliament supports resolution on affordable and accessible corona vaccines
Webinar on public investment in medicines in Europe
The European Alliance for Responsible R&D and Affordable medicines organised in cooperation with Wemos, SOMO, Salud por Derecho, StopAids and Global Justice Now a webinar on public investments in biomedical research and development (R&D). The…
Overpriced drugs: SOMO and Wemos publication discussed in Dutch parliament
Overpriced drugs developed with tax money
Research shows major Dutch public investment in drug development Overpriced, a report published today jointly by SOMO and Wemos examines the extent of Dutch public funding of drug development, through donations, loans and/or investments. This…
Overpriced
Drugs Developed with Dutch Public Funding
Position on supplementary protection certificates for medicinal products
In this joint statement, several civil society organisations have expressed their major concerns about the role of supplementary protection certificates (SPCs) in the accessibility and price of medicines in the Netherlands and elsewhere in Europe….
Share this